Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types
from UT Southwestern Medical Center via Lab Manager
Researchers from UT Southwestern Medical Center have developed a first-of-its-kind nanoparticle vaccine immunotherapy that targets several different cancer types. The nanovaccine consists of tumor antigens — tumor proteins that can be recognized by the immune system — inside a synthetic polymer nanoparticle. Nanoparticle vaccines deliver minuscule particulates that stimulate the immune system to mount an immune response.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063